Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health
Review articlePrimary aldosteronism and pregnancy
Section snippets
1. Introduction
Chronic hypertension is estimated to complicate approximately 1.8% of pregnancies, and is associated with significant foetal and maternal morbidity and mortality [1]. Secondary causes of hypertension are estimated to complicate approximately 0.24% of pregnancies. Primary aldosteronism (PA) is the most common cause of secondary hypertension in non-pregnant subjects, accounting for approximately 7.4% of cases of secondary hypertension in subjects between the age of 18 and 40 years [2]. Excluding
2. Methods and materials
A search was conducted of the National Library of Medicine’s MEDLINE/PubMed with the objective of identifying all articles published in English language between January 1960 and May 2015 with “pregnancy” and “aldosteronism” or “aldosterone” in the title or abstract. The reference lists of all articles identified by this search strategy were examined and selected those manuscripts judged to be relevant. All pertinent reports were retrieved and the relative reference lists were systematically
3. Cases
Five pregnancies to 4 women with primary aldosteronism are described, and the literature reviewed.
4. Literature review and discussion
In previously reported cases of pregnancy in women with PA the age of subjects varied between 17 and 40 years at diagnosis [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18]. Thirty-two per cent of the subjects had been diagnosed with hypertension prior to conception, 41% were noted to be hypertensive for the first time in second trimester, and 27% were first noted to have hypertension in the peripartum period. The underlying cause of PA was available in 32 cases.
5. Diagnosis
Pregnancy is a state of hyperreninemic hyperaldosteronism. Progesterone levels increase throughout gestation due to placental production [24]. Progesterone acts as an antagonist at the mineralocorticoid receptor and as a result aldosterone levels rise in parallel with the changes in progesterone. Plasma aldosterone increases 3–8-fold during gestation plateauing in third trimester. Plasma renin activity (PRA) rises by approximately 4-fold by 8 weeks gestation and 7-fold at term due to oestrogen
6.1. Surgical
Nine subjects with PA underwent laparoscopic adrenalectomy between 14 and 24 weeks gestation [9], [13], [15], [17]. Despite biochemically documented cure of hyperaldosteronism these pregnancies were associated with significant foetal morbidity and mortality. One case of IUFD occurred at 26 weeks gestation, there were two deliveries at 26 weeks gestation because of IUGR associated with foetal distress, and one delivery at 34 weeks gestation. There were 5 term deliveries. Adrenalectomy during
7. Conclusion
It is likely that PA is significantly underdiagnosed in pregnancy. PA should be considered and ARR measured in all women with hypertension pre-conception or during pregnancy, especially where hypokalaemia or proteinuria is present, the onset of hypertension occurs prior to 20 weeks gestation, or where there is the development or exacerbation of hypertension postpartum. Physiological changes in serum aldosterone and PRA in pregnancy may result in falsely negative ARR in pregnant women with PA in
Funding
No funding received for this manuscript.
Conflict of interest
No conflict of interest.
References (43)
- et al.
Management of adrenal tumors in pregnancy
Endocrinol. Metab. Clin. North Am.
(2015) - et al.
Primary hyperaldosteronism in pregnancy
Am. J. Obstet. Gynecol.
(1986) - et al.
The addition of a diuretic to anti-hypertensive therapy for early severe hypertension in pregnancy
Int. J. Gynaecol. Obstet.
(1998) - et al.
Secondary hypertension in pregnancy
Curr. Hypertens. Rep.
(2015) - et al.
Prevalence of secondary hypertension in young hypertensive adults
J. Hypertens.
(2015) - et al.
Systematic review of phaeochromocytoma in pregnancy
Br. J. Surg.
(2013) - et al.
Cushing’s syndrome during pregnancy: personal experience and review of the literature
J. Clin. Endocrinol. Metab.
(2005) - et al.
Pregnancy normalized familial hyperaldosteronism type I: a novel role for progesterone?
J. Hum. Hypertens.
(2015) - et al.
Diagnosis and management of primary aldosteronism in pregnancy: case report and review of the literature
Am. J. Perinatol.
(2002) - et al.
An adverse pregnancy-associated outcome due to overlooked primary aldosteronism
Intern. Med.
(2014)
An endocrine cause of acute post-partum hypertensive cardiomyopathy
Obstetric Med.
Laparoscopic adrenalectomy due to primary aldosteronism during pregnancy
Hinyokika Kiyo
Primary aldosteronism in pregnancy
Acta Clin. Belg.
A case of primary aldosteronism in pregnancy: do LH and GNRH receptors have a potential role in regulating aldosterone secretion?
Eur. J. Endocrinol.
Progesterone increase counteracts aldosterone action in a pregnant woman with primary aldosteronism
Clin. Endocrinol. (Oxf)
Laparoscopic treatment of primary hyperaldosteronism in a pregnant patient
Can. J. Surg.
Primary aldosteronism and pregnancy: a case report
Aust. N. Z. J. Obstet. Gynaecol.
Primary aldosteronism with aldosterone-producing adenoma consisting of pure zona glomerulosa-type cells in a pregnant woman
Endocr. Pathol.
Conn’s syndrome in pregnancy successfully treated with amiloride
J. Obstet. Gynaecol.
Laparoscopic adrenalectomy on a patient with primary aldosteronism during pregnancy
Endocr. J.
Eplerenone use in primary aldosteronism during pregnancy
Hypertension
Cited by (38)
Endocrine hypertension in pregnancy
2022, Endocrine Hypertension: From Basic Science to Clinical PracticeScreening for primary aldosteronism in pregnancy
2021, Pregnancy HypertensionCitation Excerpt :PA during pregnancy is associated with a significant risk of fetal and maternal morbidity and mortality. Complications include preeclampsia (31%), HELLP (Haemolysis, Elevated Liver Enzymes and Low Platelets) syndrome (6%), placental abruption (13%), preterm birth (48%), fetal growth restriction (15%), stillbirth and neonatal death (13%), maternal pulmonary oedema (6%), and maternal acute kidney injury (2%) [3–8]. The available literature suggests that PA does not appear to influence the mode of delivery [3].
Physiological Changes and Cardiovascular Investigations in Pregnancy
2021, Heart Lung and CirculationThe 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism
2020, International Journal of Cardiology: HypertensionAdrenal Pathologies During Pregnancy and Postpartum
2020, Maternal-Fetal and Neonatal Endocrinology: Physiology, Pathophysiology, and Clinical ManagementEvaluation and Management of Endocrine Hypertension During Pregnancy
2019, Endocrinology and Metabolism Clinics of North AmericaCitation Excerpt :Adverse outcomes have been reported in 44% of pregnancies after laparoscopic adrenalectomy.11 Despite the biochemical cure of inappropriate aldosterone secretion, significant fetal morbidity and mortality have been reported (intrauterine fetal death16 as well as preterm deliveries associated with fetal distress11). It cannot be excluded, however, that intrauterine fetal death has been caused by reduced fetal blood flow (related to hypertension in mother) already present before surgery.16